D-1387-2020 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-1387-2020 was initiated by RemedyRepack Inc. on Jun 29, 2020 and is designated Class II. Reason for recall: FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing. The recall status is terminated (terminated Sep 14, 2020). Affected quantity: 498 tablets.

Recall details

Product Type
Drugs
Report Date
Jul 22, 2020
Initiation Date
Jun 29, 2020
Termination Date
Sep 14, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
498 tablets

Product description

Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.

Reason for recall

FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.

Distribution pattern

Product was distributed to MN.

Code information

Lot #: B0796217-020920, Exp. Date: 02/28/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1387-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1387-2020. Report a data issue: hello@regdatalab.com.